MEMBERS Trust Co bought a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 3,137 shares of the healthcare conglomerate’s stock, valued at approximately $514,000.

A number of other hedge funds also recently made changes to their positions in the stock. Ameriprise Financial Inc. boosted its stake in shares of UnitedHealth Group by 29.9% in the first quarter. Ameriprise Financial Inc. now owns 3,332,761 shares of the healthcare conglomerate’s stock valued at $546,574,000 after buying an additional 766,573 shares during the period. Swiss National Bank boosted its stake in shares of UnitedHealth Group by 25.8% in the first quarter. Swiss National Bank now owns 3,719,488 shares of the healthcare conglomerate’s stock valued at $610,033,000 after buying an additional 763,161 shares during the period. Teachers Advisors LLC boosted its stake in shares of UnitedHealth Group by 56.8% in the fourth quarter. Teachers Advisors LLC now owns 1,929,490 shares of the healthcare conglomerate’s stock valued at $308,796,000 after buying an additional 698,955 shares during the period. Karp Capital Management Corp bought a new stake in shares of UnitedHealth Group during the first quarter valued at about $113,729,000. Finally, Old Mutual Global Investors UK Ltd. bought a new stake in shares of UnitedHealth Group during the first quarter valued at about $109,807,000. 86.37% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Incorporated (UNH) traded up 0.38% during trading on Friday, hitting $193.31. The company’s stock had a trading volume of 699,639 shares. UnitedHealth Group Incorporated has a one year low of $132.39 and a one year high of $196.04. The firm has a market cap of $186.90 billion, a PE ratio of 23.22 and a beta of 0.64. The company has a 50-day moving average of $189.18 and a 200 day moving average of $174.51.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.38 by $0.08. The firm had revenue of $50.05 billion during the quarter, compared to analysts’ expectations of $49.97 billion. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. The firm’s revenue for the quarter was up 7.7% on a year-over-year basis. During the same period in the prior year, the company posted $1.96 earnings per share. On average, equities analysts forecast that UnitedHealth Group Incorporated will post $9.87 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: “MEMBERS Trust Co Buys New Position in UnitedHealth Group Incorporated (NYSE:UNH)” was published by Watch List News and is the sole property of of Watch List News. If you are viewing this news story on another site, it was stolen and reposted in violation of United States & international trademark & copyright legislation. The original version of this news story can be read at https://www.watchlistnews.com/members-trust-co-buys-new-position-in-unitedhealth-group-incorporated-nyseunh/1475401.html.

A number of analysts have recently weighed in on UNH shares. Zacks Investment Research cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Friday, May 19th. Deutsche Bank AG reissued a “buy” rating and issued a $187.00 price objective (up previously from $183.00) on shares of UnitedHealth Group in a research report on Saturday, April 22nd. Mizuho raised their price objective on UnitedHealth Group from $178.00 to $200.00 and gave the stock a “buy” rating in a research report on Tuesday, April 18th. Vetr raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $186.50 price objective for the company in a research report on Tuesday, May 30th. Finally, Cantor Fitzgerald reissued an “overweight” rating and issued a $208.00 price objective on shares of UnitedHealth Group in a research report on Friday, July 21st. One investment analyst has rated the stock with a hold rating and twenty-four have assigned a buy rating to the stock. The stock has an average rating of “Buy” and a consensus target price of $200.24.

In related news, Director Gail R. Wilensky sold 5,540 shares of the stock in a transaction dated Friday, June 2nd. The shares were sold at an average price of $178.74, for a total transaction of $990,219.60. Following the completion of the transaction, the director now directly owns 60,516 shares of the company’s stock, valued at $10,816,629.84. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director William C. Ballard, Jr. sold 5,000 shares of the stock in a transaction dated Thursday, August 3rd. The stock was sold at an average price of $193.98, for a total transaction of $969,900.00. Following the transaction, the director now directly owns 76,058 shares of the company’s stock, valued at $14,753,730.84. The disclosure for this sale can be found here. Insiders have sold 15,540 shares of company stock valued at $2,873,320 over the last three months. 0.89% of the stock is currently owned by corporate insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.